BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
McKinsey
Harvard Business School
Cantor Fitzgerald
Johnson and Johnson
Fuji
Merck
Julphar
Colorcon

Generated: January 21, 2018

DrugPatentWatch Database Preview

Cabergoline - Generic Drug Details

« Back to Dashboard

What are the generic sources for cabergoline and what is the scope of cabergoline patent protection?

Cabergoline
is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Apotex Corp, Impax Labs Inc, Ivax Sub Teva Pharms, Mylan Pharms Inc, Par Pharm, and Pharmacia And Upjohn, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cabergoline. Five suppliers are listed for this compound.
Pharmacology for cabergoline
Ingredient-typeErgolines
Drug ClassErgot Derivative

US Patents and Regulatory Information for cabergoline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc CABERGOLINE cabergoline TABLET;ORAL 078035-001 Apr 21, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DOSTINEX cabergoline TABLET;ORAL 020664-001 Dec 23, 1996 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CABERGOLINE cabergoline TABLET;ORAL 077750-001 Mar 7, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Corp CABERGOLINE cabergoline TABLET;ORAL 201503-001 Mar 8, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm CABERGOLINE cabergoline TABLET;ORAL 076310-001 Dec 29, 2005 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc CABERGOLINE cabergoline TABLET;ORAL 077843-001 Jul 3, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc CABERGOLINE cabergoline TABLET;ORAL 202947-001 Dec 2, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
AstraZeneca
Moodys
US Army
Healthtrust
Merck
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot